This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Jun 26;353(9171):2173-4.

doi: 10.1016/S0140-6736(99)00128-2.

Time to genotype for selection of antiretroviral regimens in previously treated patients?

J Falloon¹

Affiliations

PMID: 10392975
DOI: 10.1016/S0140-6736(99)00128-2

Comment

Time to genotype for selection of antiretroviral regimens in previously treated patients?

J Falloon. Lancet. 1999.

. 1999 Jun 26;353(9171):2173-4.

doi: 10.1016/S0140-6736(99)00128-2.

Author

J Falloon¹

Affiliation

¹ Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

PMID: 10392975
DOI: 10.1016/S0140-6736(99)00128-2

No abstract available

PubMed Disclaimer

Comment on

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.
Durant J, Clevenbergh P, Halfon P, Delgiudice P, Porsin S, Simonet P, Montagne N, Boucher CA, Schapiro JM, Dellamonica P. Durant J, et al. Lancet. 1999 Jun 26;353(9171):2195-9. doi: 10.1016/s0140-6736(98)12291-2. Lancet. 1999. PMID: 10392984 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information